The DOI matches its Crossref record; 104 of the 105 references it cites were found in a registry or an index.
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
Open accessAbstract
Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinsonism, is now recognised as a range of motor and behavioural syndromes that are associated with a characteristic 4-repeat tau neuropathology. New research criteria that recognise early presentations of PSP and operationalise diagnosis of the full spectrum of clinical phenotypes have been reported. The Movement Disorders Society PSP diagnostic criteria include syndromes with few or mild symptoms that are suggestive of underlying PSP pathology and could provide an opportunity for earlier therapeutic interventions in the future. These criteria also include definitions for variant PSP syndromes with different patterns of movement, language, or behavioural features than have been conclusively associated with PSP pathology. Data from new diagnostic biomarkers can be combined with the clinical features of disease to increase the specificity of the new criteria for underlying PSP pathology. Because PSP is associated with tau protein abnormalities, there is growing interest in clinical trials of new tau-directed therapies. These therapies are hypothesised to have disease-modifying effects by reducing the concentration of toxic forms of tau in the brain or by compensating for loss of tau function. Since tau pathology is also central to Alzheimer's disease and chronic traumatic encephalopathy, a successful tau therapeutic for PSP might inform treatment of other neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although the presence of an overt frontotemporal dementia syndrome can be defined on the basis of established criteria, there are no such criteria for the prodromal forms of fronto temporal lobar degeneration, except for progressive supranuclear See Online for appendix Review palsy.31”
From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [31]
In the citing paper
“Neuropathologically, PSP is defined by the accumulation of pTau in both neurons and glial cells.369”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [369]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Appelhof, B., Bakker, C., den IJssel, J. C. L. V. D., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,774
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Self-citationClinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., Mollenhauer, B., Müller, U., Nilsson, C., Whitwell, J. L., et al. (2017) · Movement Disorders · doi:10.1002/mds.26987 · Cited by 2,434
Self-citationQualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia
van den Berg, E., Jiskoot, L. C., Grosveld, M. J. H., Swieten, J. C. V., & Papma, J. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477538 · Cited by 2,065
Progressive Supranuclear Palsy
Steele, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,930
Criteria for the diagnosis of corticobasal degeneration
Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., Boxer, A. L., Dickson, D. W., Grossman, M., Hallett, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0fd1 · Cited by 1,904
Self-citationDepletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
MDS research criteria for prodromal Parkinson's disease
Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G. M., Joseph, L., et al. (2015) · Movement Disorders · doi:10.1002/mds.26431 · Cited by 1,394
Self-citation
Cited by
Sorted by citations
Items 101–200 of 486
“Parkinson’s disease” on the way to progressive supranuclear palsy: a review on PSP-parkinsonism
Necpál, J., Borsek, M., & Jeleňová, B. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05601-8 · Cited by 28
Therapeutic Management of the Overlapping Syndromes of Atypical Parkinsonism
Giagkou, N., & Stamelou, M. (2018) · CNS Drugs · doi:10.1007/s40263-018-0551-3 · Cited by 26
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Poloni, T. E., Medici, V., Carlos, A. F., Davin, A., Ceretti, A., Mangieri, M., Cassini, P., Vaccaro, R., Zaccaria, D., Abbondanza, S., et al. (2020) · Journal of Visualized Experiments · doi:10.3791/60296 · Cited by 28
Shen, B., Wei, S., Ge, J., Peng, S., Liu, F., Li, L., Guo, S., Wu, P., Zuo, C., Eidelberg, D., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102416 · Cited by 26
Illán‐Gala, I., Falgàs, N., Friedberg, A., Castro‐Suárez, S., Keret, O., Rogers, N., Öz, D., Nigro, S. L., Quattrone, A., Quattrone, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.1290 · Cited by 27
Self-citationClinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
Viscidi, E., Litvan, I., Dam, T., Juneja, M., Li, L., Krzywy, H., Eaton, S., Hall, S. A., Kupferman, J., & Höglinger, G. U. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.571800 · Cited by 26
Self-citationParkinsonian syndromes: A review
Srivanitchapoom, P., Pitakpatapee, Y., & Suengtaworn, A. (2018) · Neurology India · doi:10.4103/0028-3886.226459 · Cited by 31
Comparing two facets of emotion perception across multiple neurodegenerative diseases
Brown, C. L., Hua, A. Y., Coster, L. D., Sturm, V. E., Kramer, J. H., Rosen, H. J., Miller, B. L., & LEVENSON, R. W. (2020) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsaa060 · Cited by 27
Progressive Supranuclear Palsy Syndrome: An Overview
Ichikawa-Escamilla, E., Velasco-Martínez, R. A., & Adalid-Peralta, L. V. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.04.008 · Cited by 31
Benussi, A., Dell’Era, V., Cantoni, V., Turrone, R., Pilotto, A., Alberici, A., Cotelli, M. S., Rizzetti, M. C., Padovani, A., & Borroni, B. (2019) · Brain stimulation · doi:10.1016/j.brs.2019.05.017 · Cited by 25
The Cortical Basal ganglia Functional Scale (CBFS): Development and preliminary validation
Lang, A. E., Stebbins, G. T., Wang, P., Jabbari, E., Lamb, R., Morris, H. R., Boxer, A. L., Boxer, A. L., Boeve, B. F., Dickerson, B. C., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.08.021 · Cited by 26
Self-citationA data-driven model of brain volume changes in progressive supranuclear palsy
Scotton, W. J., Bocchetta, M., Todd, E. G., Cash, D. M., Oxtoby, N. P., VandeVrede, L. A., Heuer, H. W., Alexander, D. C., Rowe, J. B., Morris, H. R., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac098 · Cited by 28
Self-citationClinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes
Campagnolo, M., Weis, L., Fogliano, C. A., Cianci, V., Garon, M., Fiorenzato, E., Carecchio, M., Ferreri, F., Bisiacchi, P. S., Antonini, A., et al. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02591-z · Cited by 25
Lannuzel, A., Edragas, R., Lackmy, A., Tressières, B., Pelonde-Erimée, V., Edimonana-Kaptue, M., Mécharles, S., Demas, A., François, B., McGovern, E. M., et al. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.02.019 · Cited by 24
Duff, K. M., McDermott, D., Luong, D., RANDOLPH, C. C., & Boxer, A. L. (2019) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2019.1572073 · Cited by 24
Self-citationVaccaro, M. G., Sarica, A., Quattrone, A., Chiriaco, C., Salsone, M., Morelli, M., & Quattrone, A. (2020) · Journal of Neuropsychology · doi:10.1111/jnp.12232 · Cited by 25
Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension
van Gerpen, J. A., Al‐Shaikh, R. H., Tipton, P. W., Wszołek, Z. K., Uitti, R. J., Ferman, T. J., Dickson, D. W., Benarroch, E. E., Singer, W., Cutsforth‐Gregory, J. K., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008197 · Cited by 24
Gazzina, S., Respondek, G., Compta, Y., Allinson, K. S. J., Spillantini, M. G., Molina‐Porcel, L., Guasp, M., Moftakhar, S., Reich, S. G., Hall, D. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/520510 · Cited by 24
Self-citationWhitney, K. R., Song, W., Sharma, A., Dangoor, D. K., Farrell, K. W., Krassner, M. M., Ressler, H. W., Christie, T. D., Kandoi, S., Walker, R. H., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02823-w · Cited by 23
Charakteristika und Dynamik der stationären Behandlung von Parkinson-Patienten in Deutschland
Tönges, L., Bartig, D., Muhlack, S., Jost, W. H., Gold, R., & Krogias, C. (2018) · Der Nervenarzt · doi:10.1007/s00115-018-0590-5 · Cited by 23
The Progressive Supranuclear Palsy: Past and Present Aspects
Parthimos, T. P., & Schulpis, K. H. (2019) · Clinical Gerontologist · doi:10.1080/07317115.2019.1694115 · Cited by 25
Dodich, A., Cerami, C., Inguscio, E., Iannaccone, S., Magnani, G., Marcone, A., Guglielmo, P., Vanoli, G., Cappa, S. F., & Perani, D. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102009 · Cited by 24
Weng, R., Wei, X., Yu, B., Zhu, S., Yang, X., Xie, F., Zhang, M., Jiang, Y., Feng, Z., Sun, H., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.03.014 · Cited by 22
Targeting Tau to Treat Clinical Features of Huntington's Disease
Masnata, M., Salem, S., Jacquet, A. D. R., Anwer, M., & Cicchetti, F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.580732 · Cited by 25
Cutaneous sensory and autonomic denervation in progressive supranuclear palsy
Dubbioso, R., Provitera, V., Vitale, F., Stancanelli, A., Borreca, I., Caporaso, G., Michele, G. D., Rosa, A. D., Picillo, M., Barone, P., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12692 · Cited by 22
Lu, J., Wang, M., Wu, P., Yakushev, I. Y., Zhang, H., Ziegler, S. I., Jiang, J., Förster, S., Wang, J., Schwaiger, M., et al. (2022) · Phenomics · doi:10.1007/s43657-022-00079-6 · Cited by 22
Hong, J., Lu, J., Liu, F., Wang, M., Li, X., Clement, C., Lopes, L. R., Brendel, M., Rominger, A., Yen, T., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104835 · Cited by 25
Shoeibi, A., Olfati, N., & Litvan, I. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1460356 · Cited by 23
Self-citationTransgenic Mouse Models for the Study of Neurodegenerative Diseases
Marín‐Moreno, A., Canoyra, S., Fernández‐Borges, N., Espinosa, J. C., & Torres, J. M. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2801021 · Cited by 21
Chen, Y., Wang, Y., Tao, Q., Lu, P., Meng, F., Zhuang, L., Qiao, S., Zhang, Y., Luo, B., Liu, Y., et al. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.118784 · Cited by 21
Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy
Zhao, P., Zhang, B., Gao, S., & Li, X. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.06.008 · Cited by 20
MRI-based neuroimaging: atypical parkinsonisms and other movement disorders
Kassubek, J. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000578 · Cited by 20
Abós, A., Segura, B., Baggio, H. C., Campabadal, A., Uribe, C., Garrido, A., Cámara, A., Muñoz, E., Valldeoriola, F., Martı́, M. J., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101899 · Cited by 19
Disease course and treatment patterns in progressive supranuclear palsy: A real-world study
Morgan, J. C., Ye, X., Mellor-Bowman, J., Golden, K. J., Zamudio, J., Chiodo, L. A., Bao, Y., & Xie, T. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117293 · Cited by 20
Nguyen, T., Cheng, J.-S., Chen, Y.-L., Lin, Y.-C., Tsai, C.-C., Lu, C.-S., Weng, Y., Wu, Y.-M., Hoang, N., & Wang, J.-J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.625874 · Cited by 20
Ortelli, P., Ferrazzoli, D., Versace, V., Cian, V., Zarucchi, M., Gusmeroli, A., Canesi, M., Frazzitta, G., Volpe, D., Ricciardi, L., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00304-z · Cited by 22
Imaging pathological tau in atypical parkinsonisms: A review
Mena, A. M., & Strafella, A. P. (2022) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2022.100155 · Cited by 20
Parmera, J. B., de Oliveira, M. C. B., Rodriguez, R. D., & Coutinho, A. M. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2022-s134 · Cited by 20
Khosousi, S., Hye, A., Velayudhan, L., Bloth, B., Tsitsi, P., Markaki, I., & Svenningsson, P. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105313 · Cited by 21
Koníčková, D., Menšíková, K., Klíčová, K., Chudáčková, M., Kaiserová, M., Vranová, H. P., Otruba, P., Nevrlý, M., Hluštík, P., Hényková, E., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15944 · Cited by 19
Gorges, M., Müller, H., & Kassubek, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00319 · Cited by 21
Classification of atypical parkinsonism per pathology versus phenotype
Respondek, G., Stamelou, M., & Höglinger, G. U. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.003 · Cited by 20
Self-citationKwasny, M., Oleske, D. M., Zamudio, J., Diegidio, R., & Höglinger, G. U. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.637176 · Cited by 19
Self-citationNovel Therapies for Parkinsonian Syndromes–Recent Progress and Future Perspectives
Przewodowska, D., Marzec, W. Z., & Madetko‐Alster, N. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.720220 · Cited by 20
Spatial attention and spatial short term memory in PSP and Parkinson's disease
Smith, D. T., Casteau, S., & Archibald, N. K. (2021) · Cortex · doi:10.1016/j.cortex.2020.12.019 · Cited by 18
Progressive apraxia of speech: delays to diagnosis and rates of alternative diagnoses
Dang, J., Graff‐Radford, J., Duffy, J. R., Utianski, R. L., Clark, H. M., Stierwalt, J. A. G., Whitwell, J. L., Josephs, K. A., & Botha, H. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10585-8 · Cited by 19
Quattrone, A., Morelli, M., Bianco, M. G., Buonocore, J., Sarica, A., Caligiuri, M. E., Aracri, F., Calomino, C., Maria, M. D., Vaccaro, M. G., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12070949 · Cited by 18
Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome
Schröter, N., Blazhenets, G., Frings, L., Barkhausen, C., Jost, W. H., Weiller, C., Rijntjes, M., & Meyer, P. T. (2020) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002949 · Cited by 18
Sánchez‐Ruiz de Gordoa, J., Erro, M. E., Vicuña‐Urriza, J., Zelaya, M. V., Tellechea, P., Acha, B., Zueco, S., Urdánoz‐Casado, A., Roldán, M., Blanco‐Luquin, I., et al. (2020) · Movement Disorders · doi:10.1002/mds.27992 · Cited by 18
Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
Mori, A., Ishikawa, K., Saiki, S., Hatano, T., Oji, Y., Okuzumi, A., Fujimaki, M., Koinuma, T., Ueno, S., Imamichi, Y., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223113 · Cited by 17
Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy
Pagonabarraga, J., Horta‐Barba, A., Busteed, L., Bejr‐Kasem, H., Illán‐Gala, I., Aracil‐Bolaños, I., Marín‐Lahoz, J., Pascual‐Sedano, B., Pérez‐Pérez, J., Campolongo, A., et al. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.03.002 · Cited by 18
Rau, A., Jost, W. H., Demerath, T., Kellner, E., Reisert, M., & Urbach, H. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac041 · Cited by 16
Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes
Chen, Q.-S., Li, X., Li, L., Lu, J., Sun, Y., Liu, F., Zuo, C., & Wang, J. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13653 · Cited by 17
Differentiating between common PSP phenotypes using structural MRI: a machine learning study
Quattrone, A., Sarica, A., Buonocore, J., Morelli, M., Bianco, M. G., Calomino, C., Aracri, F., Maria, M. D., Vescio, B., Vaccaro, M. G., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11892-y · Cited by 17
Wuehr, M., Peto, D. K., Fietzek, U. M., Katzdobler, S., Nübling, G., Zaganjori, M., Brendel, M., Levin, J., Höglinger, G. U., & Zwergal, A. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12419-9 · Cited by 17
Self-citationFrontotemporal dementia is the leading cause of “true” A−/T+ profiles defined with Aβ42/40 ratio
Pouclet‐Courtemanche, H., Nguyen, T., Skrobala, E., Boutoleau‐Bretonnière, C., Pasquier, F., Bouaziz-Amar, É., Bigot‐Corbel, E., Schraen‐Maschke, S., Dumurgier, J., Paquet, C., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.01.001 · Cited by 18
Ahn, J. H., Kim, M., Kim, J. S., Youn, J., Jang, W., Oh, E., Lee, P. H., Koh, S., Ahn, T., & Cho, J. W. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.07.009 · Cited by 17
Functional MRI in Atypical Parkinsonisms
Agosta, F., Sarasso, E., & Filippi, M. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.09.002 · Cited by 17
Duff, K. M., RANDOLPH, C. C., & Boxer, A. L. (2019) · The Clinical Neuropsychologist · doi:10.1080/13854046.2019.1670865 · Cited by 16
Self-citationOu, R., Wei, Q., Hou, Y., Zhang, L., Liu, K., Xu, X., Gu, X., Lin, J., Jiang, Z., Liu, J., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.127 · Cited by 20
Wunderlich, J., Behler, A., Dreyhaupt, J., Ludolph, A. C., Pinkhardt, E. H., & Kassubek, J. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10522-9 · Cited by 16
Peripapillary retinal nerve fiber layer thinning in patients with progressive supranuclear palsy
Woo, K. A., Shin, J. Y., Kim, H., Ahn, J., Jeon, B., & Lee, J. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10936-5 · Cited by 15
One decade ago, one decade ahead in progressive supranuclear palsy
Stamelou, M., Giagkou, N., & Höglinger, G. U. (2019) · Movement Disorders · doi:10.1002/mds.27788 · Cited by 14
Self-citationModelling the functional genomics of Parkinson’s disease inCaenorhabditis elegans:LRRK2and beyond
Chandler, R. J., Cogo, S., Lewis, P. A., & Kevei, É. (2021) · Bioscience Reports · doi:10.1042/bsr20203672 · Cited by 16
Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations
Brittain, C., McCarthy, A. P., Irizarry, M. C., McDermott, D., Biglan, K., Höglinger, G. U., Lorenzl, S., del Ser, T., Boxer, A. L., Williams, D. R., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.08.025 · Cited by 16
Self-citationClinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy
Picillo, M., Cuoco, S., Carotenuto, I., Abate, F., Erro, R., Volpe, G., Pellecchia, M. T., Catricalà, E., Cappa, S. F., & Barone, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223621 · Cited by 15
Retina thickness in atypical parkinsonism: a systematic review and meta-analysis
Ma, X., Wang, Y., Wang, N., & Zhang, R. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10703-6 · Cited by 14
I'm looking through you: Mentalizing in frontotemporal dementia and progressive supranuclear palsy
de Souza, L. C., Bertoux, M., Radaković, R., Hornberger, M., Mariano, L. I., Resende, E. D. P. F., Quesque, F., Guimarães, H. C., Gambogi, L. B., Tumas, V., et al. (2022) · Cortex · doi:10.1016/j.cortex.2022.07.015 · Cited by 16
Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review
Dunning, E. E., Decourt, B., Zawia, N. H., Shill, H. A., & Sabbagh, M. N. (2024) · Neurology and Therapy · doi:10.1007/s40120-024-00614-9 · Cited by 20
Biomarkers of disease progression in progressive supranuclear palsy for use in clinical trials
Marotta, C., Sinclair, B., O'Brien, T. J., & Vivash, L. E. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf022 · Cited by 14
Long non‐coding RNAs as key regulators of neurodegenerative protein aggregation
Xu, Q., Liu, D., Zhu, L., Su, Y., & Huang, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14498 · Cited by 15
Therapeutic strategies for tauopathies and drug repurposing as a potential approach
Islam, M., Shen, F., Regmi, D., & Du, D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114979 · Cited by 14
Rogozinski, S., Klietz, M., Respondek, G., Oertel, W. H., Grothe, M. J., Pereira, J. B., & Höglinger, G. U. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.851788 · Cited by 14
Self-citationNojszewska, M., Potulska‐Chromik, A., Jamrozik, Z., Janik, P., & Zakrzewska‐Pniewska, B. (2018) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2019.0005 · Cited by 14
Pyramidal system involvement in progressive supranuclear palsy – a clinicopathological correlation
Stejskalova, Z., Rohan, Z., Rusina, R., Tesař, A., Kukal, J., Kovács, G. G., Bartoš, A., & Matěj, R. (2019) · BMC Neurology · doi:10.1186/s12883-019-1270-1 · Cited by 14
Transcranial photobiomodulation therapy: observations from four movement disorder patients
Hamilton, C., Hamilton, D. J., Nicklason, F., & Mitrofanis, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815305-5.00033-6 · Cited by 14
Rohmann, R., Kuhn, E. M., Scherbaum, R., Hilker, L., Kools, S., Scholz, L., Müller, K., Huckemann, S., Schneider‐Gold, C., Gold, R., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11070879 · Cited by 13
A seeding-based neuronal model of tau aggregation for use in drug discovery
Amorim, I. S., Challal, S., Cistarelli, L., Dorval, T., Abjean, L., Touzard, M., Arbez, N., François, A., Panayi, F., Jeggo, R., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283941 · Cited by 14
Schweyer, K., Busche, M. A., Hammes, J., Zwergal, A., Buhmann, C., van Eimeren, T., & Höglinger, G. U. (2018) · Neurology · doi:10.1212/wnl.0000000000005069 · Cited by 13
Self-citationValidation of the Italian version of the PSP Quality of Life questionnaire
Picillo, M., Cuoco, S., Amboni, M., Bonifacio, F. P., Bruschi, F., Carotenuto, I., Micco, R. D., Rosa, A. D., Prete, E. D., Biasio, F. D., et al. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04010-2 · Cited by 13
King, G., Veros, K. M., MacLaren, D. A. A., Leigh, M. P. K., Spernyak, J. A., & Clark, S. D. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15496 · Cited by 12
Clinical features of progressive supranuclear palsy
Wen, Y., Yang, Q., Jiao, B., Zhang, W., Lin, J., Zhu, Y., Xu, Q., Zhou, H., Weng, L., Liao, X., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1229491 · Cited by 13
Talai, A. S., Ismail, Z., Sedlacik, J., Boelmans, K., & Forkert, N. D. (2018) · Clinical Neuroradiology · doi:10.1007/s00062-018-0727-8 · Cited by 13
Emotion regulation via visual avoidance: Insights from neurological patients
Otero, M. C., & LEVENSON, R. W. (2019) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2019.05.003 · Cited by 14
Valentino, R. R., Tamvaka, N., Heckman, M. G., Johnson, P. W., Soto‐Beasley, A. I., Walton, R. L., Koga, S., Uitti, R. J., Wszołek, Z. K., Dickson, D. W., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01035-z · Cited by 13
Tau mis-splicing correlates with motor impairments and striatal dysfunction in a model of tauopathy
Damianich, A., Facal, C. L., Muñiz, J. A., Mininni, C. J., Soiza‐Reilly, M., de León, M. P., Urrutia, L., Falasco, G., Ferrario, J. E., & Avale, M. E. (2021) · Brain · doi:10.1093/brain/awab130 · Cited by 14
Overcoming challenges of clinical cell therapies for Parkinson's disease with photobiomodulation
Chamkouri, H., Si, J., Chen, P., Ni, H., Bragin, D. E., Ahmadlouydarab, M., Niu, C., & Chen, L. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20240013 · Cited by 12
Ethnic Differences in Atypical Parkinsonism—is South Asian PSP Different?
Balint, B., Neo, S., Magrinelli, F., Mulroy, E., Latorre, A., Stamelou, M., Morris, H. R., Batla, A., & Bhatia, K. P. (2024) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.14182 · Cited by 12
The Clinical Spectrum of Young Onset Dementia Points to Its Stochastic Origins
Panegyres, P. K. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210309 · Cited by 12
Imaging correlates of depression in progressive supranuclear palsy
Urso, D., Tafuri, B., Blasi, R. D., Nigro, S. L., Logroscino, G., & Initiative, F. T. 4.-R. T. N. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10939-2 · Cited by 12
Tau Diagnostics and Clinical Studies
Gozes, I., Höglinger, G. U., Quinn, J. P., Hooper, N. M., & Höglund, K. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0983-0 · Cited by 12
Self-citationProgress in the treatment of Parkinson-Plus syndromes
Olfati, N., Shoeibi, A., & Litvan, I. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.10.006 · Cited by 16
Self-citationYao, N.-T., Zheng, Q., Xu, Z., Yin, J., Lu, L.-G., Zuo, Q., Yang, S. S., Zhang, C., & Jiao, L. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000836 · Cited by 13
Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies
Endres, D., Prüß, H., Rijntjes, M., Schweizer, T., Werden, R., Nickel, K., Meixensberger, S., Runge, K., Urbach, H., Domschke, K., et al. (2020) · Brain Sciences · doi:10.3390/brainsci10060399 · Cited by 12
Takahashi, K., Iwaoka, K., Takahashi, K., Suzuki, Y., Taguchi, K., Yamahara, K., & Maeda, T. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135975 · Cited by 12
Genetics of progressive supranuclear palsy in a Chinese population
Xiao, X., Yang, Q., Wen, Y., Jiao, B., Liao, X., Zhou, Y., Weng, L., Liu, H., Xu, T., Zhu, Y., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105819 · Cited by 11
Xie, T., Wills, A.-M. A., Liao, C., Dale, M. L., Ramsden, D. B., Padmanaban, M., Chaar, W. A., Pantelyat, A. Y., & Golbe, L. I. (2022) · Movement Disorders · doi:10.1002/mds.29299 · Cited by 11
Self-citationPragmatic algorithm for visual assessment of 4-Repeat tauopathies in [18F]PI-2620 PET Scans
Bauer, T., Brendel, M., Zaganjori, M., Bernhardt, A. M., Jäck, A., Stöcklein, S., Scheifele, M., Levin, J., van Eimeren, T., Drzezga, A. E., et al. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121001 · Cited by 13
Self-citationAbbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Poloni, T. E., Medici, V., Carlos, A. F., Davin, A., Ceretti, A., Mangieri, M., Cassini, P., Vaccaro, R., Zaccaria, D., Abbondanza, S., et al. (2020) · Journal of Visualized Experiments · doi:10.3791/60296-v · Cited by 11
Havlicek, D. F., Furhang, R., Nikulina, E., Smith-Salzberg, B., Lawless, S., Severin, S., Mallaboeva, S., Nayab, F., Seifert, A. C., Crary, J. F., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114241 · Cited by 11
Metadata
- Authors
- Boxer, A. L., Yu, J.-T., Golbe, L. I., Litvan, I., Lang, A. E., & Höglinger, G. U.
- Affiliations
- University of California, San Francisco (US)
- Qingdao University (CN)
- Rutgers, The State University of New Jersey (US)
- University of California San Diego (US)
- University of Toronto (CA)
- German Center for Neurodegenerative Diseases (DE)
- Corresponding author
- Boxer, Adam L
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 16
- Issue
- 7
- Pages
- 552-563
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC5802400
- OpenAlex
- W2625168757
- Cited by
- 485
- References
- 105
- Citations by year
- 2026: 45 · 2025: 52 · 2024: 59 · 2023: 42 · 2022: 57 · 2021: 56 · 2020: 62 · 2019: 61 · 2018: 43 · 2017: 7
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (HO2402/6‐2)
- National Institutes of Health
- National Institute on Aging (P50AG005131, U01AG045390, R01AG038791, P01AG019724)
- National Heart, Lung, and Blood Institute (T35HL007491)
- National Institute of Neurological Disorders and Stroke (U01NS086659, U54NS092089)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- progressive supranuclear palsy, diagnostic criteria, tau pathology, 4-repeat tau, biomarkers, atypical parkinsonism, disease-modifying therapy, neurodegenerative diseases, Alzheimer's disease, chronic traumatic encephalopathy
- MeSH terms
- Humans, Supranuclear Palsy, Progressive, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
